Adding to Its International Growth, Med-Rite® Laboratories, the Makers of Hemor*Rite® Cryotherapy, Announce Distribution in Spain, Portugal, Greece & the Czech Republic
Already being sold in the Kingdom of Saudi Arabia, Iran, India, Israel, and the United Kingdom, Hemor*Rite® Cryotherapy the new, Drug-Free, Class II Medical Device is rapidly gaining worldwide appeal.
DALLAS, June 5, 2012 /PRNewswire/ -- Med-Rite® Laboratories (www.medritelabs.com), the makers of Hemor*Rite® Cryotherapy announce today that their breakthrough product is being marketed and sold in Spain by BioMed Laboratories, in Greece by Emergy Products and in the Czech Republic by Medimport.
Larry Ferk, the VP of Global Sales for Med-Rite® states, "We are thrilled that unparalleled relief and effective treatment that Hemor*Rite® provides is catching on so quickly in the international arena. We are available in Kingdom of Saudi Arabia, Iran, India, Israel, and the United Kingdom and have just added the top medical distributors in Spain, Portugal, Greece and Czech Republic, with additional countries pouring in."
Hemor*Rite® Cryotherapy is made by Dallas-based Med-Rite® Laboratories and is a FDA/CE approved, drug free, ergonomically designed Class II medical device that treats hemorrhoids with zero side effects and does not increase blood pressure. This breakthrough treatment applies cold therapy directly to swollen hemorrhoid veins and provides immediate and long lasting relief of bleeding, itching, pain and swelling, safe for both diabetics and pregnant women. Each box contains a six month supply.
Eduardo Ruiz, CEO of BioMed Laboratories in Spain says, "Hemor*Rite® Cryotherapy has created so much anticipation to finally have a new clinically proven alternative that doctors can recommend to patients all over Spain and Portugal."
Peter Milios, Director of International Marketing, at Emergy in Greece states, "Our doctors believe this product is the answer to painful hemorrhoids that have plagued patients for years. Emergy is proud to educate doctors, pharmacists and most importantly, patients, about Hemor*Rite®."
And Jolana Gunes, Business Development Manager, Medimport, Czech Republic adds, "[We] will participate in the 2012 National GYN Congress and will use this event as official launch platform for Hemor*Rite® Cryotherapy."
Hemorrhoids are a very common yet painful human condition. It's estimated that 50% of the world's population will have experienced hemorrhoids by the age of 50. Many diabetics, body builders, pregnant women and the obese commonly also suffer from this affliction. If left untreated, the condition of the rectal cavity and its functions may worsen.
Med-Rite® Laboratories has patented the FDA "tested and approved safe" Hemor*Rite® Cryotherapy device for applying cold therapy (Cryotherapy) directly to the swollen hemorrhoid veins and blood vessels of both external and internal hemorrhoids. The direct application of cold provides prompt relief of bleeding, itching, pain, and swelling. Hemor-Rite® Cryotherapy is designed for the human anatomy and is lubricated with 100% natural glycerin for easy glide insertion and provides the most effective, long lasting treatment for moderate to severe hemorrhoids.
Contact: Kim Morgan
Simply the Best Public Relations
(561) 210-4411
[email protected]
SOURCE Med-Rite Laboratories
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article